Related references
Note: Only part of the references are listed.Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses
Mike D. Shelley et al.
CANCER TREATMENT REVIEWS (2010)
Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guérin (BCG) immunotherapy
A. M. JACKSON et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy
Dinesh K. Ahirwar et al.
BIOMARKERS (2009)
Association of tumour necrosis factor-α gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy
Dinesh K. Ahirwar et al.
BJU INTERNATIONAL (2009)
Bacille-Calmette Guerin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1
William A. See et al.
BJU INTERNATIONAL (2009)
More than skin deep: atherosclerosis as a systemic manifestation of psoriasis
A. B. Alexandroff et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Report from the 67th Annual Meeting of the American Academy of Dermatology
A.B. Alexandroff et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth
Tomoe Higuchi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Bladder Tumor Infiltrating Mature Dendritic Cells and Macrophages as Predictors of Response to Bacillus Calmette-Guerin Immunotherapy
Cherifa Ayari et al.
EUROPEAN UROLOGY (2009)
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer
Per-Uno Malmstrom et al.
EUROPEAN UROLOGY (2009)
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Natalia Martin-Orozco et al.
IMMUNITY (2009)
Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder
Timothy P. Kresowik et al.
IMMUNOTHERAPY (2009)
Development and function of TH17 cells in health and disease
Jennifer Louten et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Bladder Cancer: Narrowing the Gap Between Evidence and Practice
Maha H. A. Hussain et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Protumor vs Antitumor Functions of IL-17
Gopal Murugaiyan et al.
JOURNAL OF IMMUNOLOGY (2009)
Intravesical Bacille Calmette-Guerin Therapy for Non-Muscle-Invasive Bladder Cancer: Effects of Concurrent Statin Therapy
Ted A. Skolarus et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt
Maha Ayyoub et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of IL-17-producing FOXP3+ regulatory T cells in humans
Kui Shin Voo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-23 and IL-17 in tuberculosis
Shabaana A. Khader et al.
CYTOKINE (2008)
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
Marko Babjuk et al.
EUROPEAN UROLOGY (2008)
From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
Katia Boniface et al.
IMMUNOLOGICAL REVIEWS (2008)
Rapid identification of mycobacteria by Raman spectroscopy
P. C. A. M. Buijtels et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
An analysis of the effect of statin use on the efficacy of bacillus Calmette-Guerin treatment for transitional cell carcinoma of the bladder
Ryan K. Berglund et al.
JOURNAL OF UROLOGY (2008)
The Foxp3(+) regulatory T cell: a jack of all trades, master of regulation
Qizhi Tang et al.
NATURE IMMUNOLOGY (2008)
Role of neutrophils in BCG immunotherapy for bladder cancer
Mark P. Simons et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Impact of previous bacille Calmette-Guerin failure pattern on subsequent response to bacille Calmette-Guerin plus interferon intravesical therapy
Brian L. Gallagher et al.
UROLOGY (2008)
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
XingWu Zhu et al.
BREAST CANCER RESEARCH (2008)
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Nicholas J. Wilson et al.
NATURE IMMUNOLOGY (2007)
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism
Janine L. Coombes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The role of granulocytes following intravesical BCG prophylaxis
Saluatore Siracusano et al.
EUROPEAN UROLOGY (2007)
Bacillus Calmette-Guerin-pulsed dendritic cells stimulate natural killer T cells and γδT cells
Michio Naoe et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Marcia R. Saban et al.
BMC IMMUNOLOGY (2007)
Mycobacterium bovis bacillus Calmette-Guerin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo
Y. Luo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling
Paweena Kreunin et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer
Mark P. Simons et al.
IMMUNOLOGIC RESEARCH (2007)
FOXP3+ regulatory T cells:: Current controversies and future perspectives
Alison H. Banham et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Role of Th1-stimulating cytokines in bacillus Calmette-Guerin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells
Y. Luo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
The effect of ofloxacin on bacillus Calmette-Guerin induced toxicity in patients with superficial bladder cancer: Results of a randomized, prospective, double-blind, placebo controlled, multicenter study
Marc Colombel et al.
JOURNAL OF UROLOGY (2006)
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon α-2B for reducing recurrence of superficial bladder cancer
Fadi N. Joudi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2005)
Importance of urinary interleukin-18 in intravesical immunotherapy with bacillus Calmette-Guerin for superficial bladder tumors
M Eto et al.
UROLOGIA INTERNATIONALIS (2005)
Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy
SL Young et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Tumor necrosis factor-related apoptosis-inducing ligand: A novel mechanism for Bacillus Calmette-Guerin-induced antitumor activity
AT Ludwig et al.
CANCER RESEARCH (2004)
Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation
H Suttmann et al.
JOURNAL OF UROLOGY (2004)
Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guerin response of superficial bladder cancer during induction course and maintenance therapy
F Saint et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guerin immunotherapy for carcinoma in situ of the bladder
E Watanabe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Mycobacterium bovis bacillus Calmette-Guerin-infected dendritic cells potently activate autologous T cells via a B7 and interleukin-12-dependent mechanism
EJ Cheadle et al.
IMMUNOLOGY (2003)
The role of LFA-1 in the lysis of bladder cancer cells by bacillus Calmette-Guerin and interleukin 2-activated killer cells
H Suttmann et al.
UROLOGICAL RESEARCH (2002)
The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2
C Magno et al.
IMMUNOLOGY LETTERS (2002)
Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Guerin (BCG): A role of BCG internalization into tumor cells
N Ikeda et al.
INTERNATIONAL JOURNAL OF UROLOGY (2002)
Activation of natural killer cells by bacillus Calmette-Guerin
S Brandau et al.
EUROPEAN UROLOGY (2001)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
ICAM-1-induced expression of proinflammatory cytokines in astrocytes: Involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways
SJ Lee et al.
JOURNAL OF IMMUNOLOGY (2000)
In vitro generation of bacillus Calmette-Guerin-activated killer cells
S Brandau et al.
CLINICAL INFECTIOUS DISEASES (2000)
Interaction of dendritic cells with mycobacteria: Where the action starts
C Demangel et al.
IMMUNOLOGY AND CELL BIOLOGY (2000)
Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12
L Heidecker et al.
JOURNAL OF IMMUNOLOGY (2000)
Role for CD40-CD40 ligand interactions in the immune response to solid tumours
AB Alexandroff et al.
MOLECULAR IMMUNOLOGY (2000)
Mechanisms of action of intravesical bacille Calmette-Guerin: Local immune mechanisms
S Prescott et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
